Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The primary objective of this study is to evaluate the safety of adjuvanted and non-adjuvanted formulations of MCV-5 vaccine. The secondary objective is to assess the immune response of adjuvanted and non-adjuvanted formulations of MCV-5 vaccine.
Epistemonikos ID: d56f362036bb41c2433c10a410af1873ed234b9e
First added on: May 17, 2024